V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013744 | 220014462 | null | 76.8 | Curative (C) | null | 2015-09-24 | AML18 PILOT TRIAL | 1 | null | 220031045 | PILOT TRIAL |
| 220013745 | 220019820 | 0 | 69 | Curative (C) | 2017-09-27 | 2017-10-04 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220031047 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013746 | 220008181 | 1.8 | 95.2 | Curative (C) | 2017-09-19 | 2017-11-28 | AML18 PILOT TRIAL | Y | N | 220031049 | PILOT TRIAL |
| 220013747 | 220008183 | 1.7 | 0 | Palliative (P) | 2014-01-19 | 2014-12-19 | Dasatinib | 99 | N | 220031051 | DASATINIB |
| 220013748 | 220014464 | 0 | 80.9 | Curative (C) | 2015-06-20 | 2015-08-04 | AML18 PILOT TRIAL | Y | N | 220031051 | PILOT TRIAL |
| 220013749 | 220008184 | 1.55 | 90.6 | Disease modification (D) | 2017-07-25 | 2017-10-24 | Rituximab | 02 | N | 220031065 | RITUXIMAB |
| 220013750 | 220008186 | 1.85 | 49.9 | null | 2013-07-17 | 2013-07-18 | Rituximab | 2 | N | 220031072 | RITUXIMAB |
| 220013751 | 220014465 | 1.75 | 84.2 | Curative (C) | 2015-10-21 | 2015-10-27 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031078 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013752 | 220014465 | 1.6 | 80 | Curative (C) | 2014-05-11 | 2014-05-11 | Rituximab | N | N | 220031078 | RITUXIMAB |
| 220013753 | 220014466 | null | 84 | Curative (C) | 2017-08-09 | 2017-08-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031093 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013754 | 220014467 | 1.79 | 102 | Curative (C) | 2016-06-06 | 2016-06-06 | AML 18 TRIAL | 01 | N | 220031094 | AML18 TRIAL |
| 220013755 | 220014468 | 1.9 | 90.35 | Curative (C) | 2017-11-06 | 2017-11-06 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220031097 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013756 | 220014468 | 1.74 | 61.8 | Curative (C) | 2018-01-26 | 2018-01-26 | AML 18 TRIAL | Y | N | 220031097 | AML18 TRIAL |
| 220013759 | 220017900 | 0 | 78 | Curative (C) | 2017-01-12 | 2017-02-13 | AML18 PILOT TRIAL | N | null | 220031113 | PILOT TRIAL |
| 220013760 | 220021553 | null | 51.3 | Disease modification (D) | 2017-07-10 | 2017-07-12 | Dasatinib | N | N | 220031113 | DASATINIB |
| 220013761 | 220008192 | 0 | 113.8 | Curative (C) | 2015-02-01 | 2015-03-21 | AML 18 TRIAL | 01 | N | 220031116 | AML18 TRIAL |
| 220013762 | 220008193 | 1.61 | 43.6 | Curative (C) | 2015-11-07 | 2015-11-08 | Rituximab | N | null | 220031119 | RITUXIMAB |
| 220013763 | 220008194 | 1.83 | 61 | Curative (C) | 2017-07-03 | 2017-07-03 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220031122 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013764 | 220008195 | 1.62 | null | Curative (C) | 2013-01-23 | 2013-06-17 | AML 18 TRIAL | Y | N | 220031128 | AML18 TRIAL |
| 220013765 | 220008196 | 0 | 0 | Curative (C) | 2017-11-16 | 2017-11-19 | AML 18 TRIAL | 01 | N | 220031130 | AML18 TRIAL |
| 220013766 | 220008197 | 0 | null | Disease modification (D) | 2017-07-29 | 2017-08-01 | Rituximab (Maintenance) | N | Y | 220031137 | RITUXIMAB |
| 220013767 | 220008198 | 1.7 | 95 | Disease modification (D) | 2016-10-12 | 2016-10-18 | Dasatinib | 99 | N | 220031139 | DASATINIB |
| 220013769 | 220014471 | 1.69 | 67 | Curative (C) | 2017-12-13 | 2017-12-13 | Dasatinib | N | N | 220031142 | DASATINIB |
| 220013770 | 220008200 | 1.61 | 71.4 | null | 2016-08-16 | 2016-08-21 | Rituximab (Maintenance) | N | null | 220031142 | RITUXIMAB |
| 220013771 | 220008200 | 1.79 | 88.4 | Curative (C) | 2017-06-12 | 2017-06-14 | AML 18 TRIAL | Y | N | 220031142 | AML18 TRIAL |
| 220013772 | 220008201 | 1.68 | 67.2 | Curative (C) | 2017-04-16 | 2017-06-11 | AML18 PILOT TRIAL | N | N | 220031173 | PILOT TRIAL |
| 220013773 | 220014473 | 1.57 | 44.2 | Curative (C) | 2013-05-31 | 2013-06-12 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031173 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013774 | 220008202 | null | 0 | Disease modification (D) | 2012-09-02 | 2013-09-25 | Dasatinib | N | N | 220031188 | DASATINIB |
| 220013775 | 220014474 | 1.6 | 0 | Curative (C) | 2016-05-10 | 2016-05-10 | Dasatinib | N | N | 220031195 | DASATINIB |
| 220013776 | 220008203 | 1.6 | 0 | Disease modification (D) | null | 2016-06-04 | Dasatinib | N | N | 220031195 | DASATINIB |
| 220013777 | 220008203 | 1.9 | 82.2 | Curative (C) | 2016-09-11 | 2016-09-15 | Dasatinib | N | N | 220031195 | DASATINIB |
| 220013778 | 220019825 | null | null | Curative (C) | 2018-02-07 | 2018-02-07 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031205 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013779 | 220008204 | 1.63 | null | Disease modification (D) | 2015-04-20 | 2015-04-20 | Rituximab | 02 | N | 220031209 | RITUXIMAB |
| 220013781 | 220008208 | null | null | Disease modification (D) | 2016-05-29 | 2016-08-23 | Dasatinib | N | N | 220031213 | DASATINIB |
| 220013782 | 220008210 | 1.88 | 82.8 | Curative (C) | 2017-07-14 | 2017-09-19 | AML18 PILOT TRIAL | N | null | 220031213 | PILOT TRIAL |
| 220013783 | 220008211 | 1.66 | 63.8 | Curative (C) | 2015-10-22 | 2015-10-22 | AML18 PILOT TRIAL | Y | N | 220031221 | PILOT TRIAL |
| 220013784 | 220008213 | 1.68 | 111.5 | Curative (C) | 2016-05-02 | 2016-05-06 | Dasatinib | 02 | N | 220031225 | DASATINIB |
| 220013785 | 220014477 | 1.8 | null | Curative (C) | 2017-06-22 | 2017-06-22 | Dasatinib | N | N | 220031227 | DASATINIB |
| 220013786 | 220008215 | 1.79 | 60 | Curative (C) | 2016-02-26 | 2016-03-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 220031228 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013787 | 220008215 | 1.72 | 70.2 | Disease modification (D) | 2017-09-10 | 2017-09-11 | Rituximab | null | N | 220031228 | RITUXIMAB |
| 220013788 | 220017905 | 1.75 | null | Curative (C) | 2016-10-11 | 2017-10-06 | Dasatinib | N | N | 220031230 | DASATINIB |
| 220013789 | 220008217 | null | null | Disease modification (D) | 2018-03-12 | 2018-03-29 | Rituximab | 02 | null | 220031232 | RITUXIMAB |
| 220013790 | 220008217 | 1.61 | 55 | Curative (C) | 2013-12-21 | 2013-12-24 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031232 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013795 | 220008220 | 0 | 57 | Curative (C) | 2018-08-06 | 2018-08-06 | Dasatinib | 02 | N | 220031249 | DASATINIB |
| 220013796 | 220014481 | null | 0 | Curative (C) | null | 2018-02-28 | Dasatinib | N | null | 220031249 | DASATINIB |
| 220013797 | 220014482 | 1.7 | 16.8 | Disease modification (D) | 2015-12-28 | 2015-12-31 | Rituximab (Maintenance) | N | N | 220031254 | RITUXIMAB |
| 220013798 | 220014482 | null | 61.3 | Curative (C) | 2017-03-02 | 2017-03-09 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 220031254 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013799 | 220014483 | 1.64 | 70.6 | Adjuvant (A) | 2014-03-22 | 2014-03-22 | AML18 PILOT TRIAL | Y | N | 220031257 | PILOT TRIAL |
| 220013800 | 220014483 | 1.77 | 77.4 | Disease modification (D) | null | 2014-05-08 | Rituximab | N | N | 220031257 | RITUXIMAB |
| 220013801 | 220019830 | 1.67 | 96.8 | Curative (C) | 2018-02-27 | 2018-03-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031258 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |